Clinical Science

Clinical Validation of Cold-Pressed Black Seed Oil

By Dr. Marcus Vance, Director of Clinical Research June 8, 2026

Black Seed Oil, derived from the seeds of Nigella sativa, has been revered for thousands of years as a multi-functional therapeutic agent. Modern clinical pharmacology is now validating many of these traditional claims, focusing heavily on its primary bioactive compound, Thymoquinone (TQ).

The Role of Thymoquinone

Thymoquinone is a powerful lipophilic antioxidant that exhibits protective effects across multiple systemic networks. Our cold-pressed black seed oil is standardized to guarantee high concentrations of TQ, ensuring consistent physiological efficacy.

Primary Physiological Benefits

  • Immune Modulation: TQ supports the regulation of inflammatory cytokines (such as IL-6 and TNF-alpha), helping the body maintain balanced immune responses.
  • Cardiovascular Support: Research indicates that daily supplementation helps support healthy lipid profiles and arterial elasticity.
  • Bronchial Health: TQ aids in relaxing smooth muscle tissues in the respiratory system, promoting clear airways.

Clinical Trial Insights

Recent double-blind, placebo-controlled trials have demonstrated that a daily dose of 1,000mg to 2,000mg of cold-pressed Nigella sativa oil leads to significant improvements in metabolic and inflammatory biomarkers over an 8-week period.

Biomarker CheckedOutcome in Treatment GroupSignificance (p-value)
Fasting Blood Sugar-12.5% Average Reductionp < 0.05
LDL Cholesterol-9.8% Average Reductionp < 0.01
High-Sensitivity CRP-15.4% Average Reductionp < 0.05

Quality & Sourcing Parameters

To maintain chemical integrity, we cold-press our seeds strictly below 45°C (113°F) without using chemical solvents like hexane. The oil is then stored in amber glass bottles under a nitrogen blanket to prevent oxidation and ensure maximum shelf-life stability.